Dr. Reddy's Laboratories, Inc. is recalling 4,320 bottles of Tacrolimus Capsules, USP (0.5 mg), an immunosuppressant medication used to prevent organ rejection. This recall was initiated after a single 1 mg capsule was discovered inside a bottle labeled as containing only 0.5 mg capsules. The affected 100-count bottles were distributed nationwide in the United States.
Taking a 1 mg capsule instead of the prescribed 0.5 mg dose could cause a patient to ingest double their intended dosage. This may lead to tacrolimus toxicity, which can result in serious health complications, including kidney impairment or neurological issues.
You have 2 options:
Mfd. by Dr. Reddy's Laboratories Limited, Bachupally, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.